Tag: Covid19
-
India to make Covaxin available in Q2 2021: Reports
As per the official reports, the first vaccine being developed in India–Covaxin will be launched by the second quarter next year. The company official confirmed that once it is approved the vaccine will be made available to the public. “If we get all the approvals after establishing strong experimental evidence and data, and efficacy and ... -
Demand for medical oxygen surges with rise in COVID-19 cases
With the rise in COVID-19 infections across various parts of India, both public and private hospitals have been facing an unprecedented rise in medical oxygen use. As per reports, demand for medical oxygen has spiked from 750-800 metric tonnes in March to 2,500 metric tonnes in recent weeks. Significantly, Coronavirus infection has damaged lung tissues ... -
Intranasal Covid-19 vaccine production commences at Pune’s Serum Institute of India
Intranasal vaccine for Covid-19 virus SARS-CoV-2 is not under any clinical trial currently, but Serum Institute of India has started production of an intranasal vaccine candidate, informed Union Health Minister Dr. Harsh Vardhan on Monday. Various Covid-19 vaccine candidates are currently under human trials in India. Dr. Harsh Vardhan said, “Flumist nasal spray is a ... -
Union Health Minister Dr. Harsh Vardhan: India’s Covid19 vaccine likely in first quarter of 2021
On Monday Union Health Minister Dr. Harsh Vardhan said that India’s first vaccine for Covid-19 is likely to be roll out for public use in first quarter of 2021. Dr. Vardhan said, “Research to develop vaccine is being done expeditiously. There are at least three viable such vaccine candidates that are in the phase of ... -
Suspended Vaccines trials restarted in India
The Serum Institute of India which had paused the trials of Oxford-AstraZeneca vaccine has been allowed to restart them. The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to continue testing the Oxford-AstraZeneca vaccine after it had been suspended on September 11, following an unexplained neurological illness in one ... -
Air pollution season is set to worsen COVID-19 in India
The country is already reeling under a record number of infections which is spiralling at an alarming rate. This is only going to get worse with pollution. India is now the second-worst coronavirus affected country in the world, overtaking Brazil and only two million infections behind the number one spot. Even as the infections spiral ... -
Bihar polls to be held as per schedule
Speaking to a news channel on Monday, Chief Election Commissioner Sunil Arora confirmed that assembly elections in Bihar will go on as per the schedule and the poll body was making all preparations against COVID-19. Earlier, the EC had asked the various political parties in the state to weigh in before August 11 on whether ... -
AIIMS Coronavirus Vaccine Trial: 1 out of 5 people who had signed up for Covaxin trial already have antibodies
A portion of people who had applied to enroll for AIIMS coronavirus vaccine trial for India’s first indigenous vaccine, Covaxin have already developed antibodies against the novel coronavirus. The sources at AIIMS said that about 20% of the enrolled people in trial have thus been rendered unfit for the trial. It has been two weeks ... -
Why Work From Home Strategy Is Working Best For India?
Indian companies are choosing the Work From Home strategy as their long term plan for their working style in the coming year. It is more of a ‘keep it safe’ strategy that is being adopted by one of the most prominent companies of India. These companies have come to the consensus that for India, working ... -
Why the sudden rise in covid cases in Karnataka?
Karnataka, especially Bengaluru, has seen a spurge in coronavirus cases and experts have predicted that by August the cases will cross five million with nearly 9,000 deaths. Initially, Karnataka was one of the states that had controlled the spread of virus well and was lauded for the strict implementations of the guidelines set by the ...